Exosomes as novel bio-carriers for gene and drug delivery.

Clinical treatments have stalled in certain diseases due to a lack of proper therapeutic delivery systems. Recent studies have identified exosomes for their potential use as cell-free therapies, which may provide a novel mechanism for solving this problem. Exosomes are nanoscale extracellular vesicles that can transport rich cargos of proteins, lipids, DNA, and RNA. It is increasingly recognized that exosomes play a complex role in not only the physiological conditions but also pathological ones. Accumulating evidence suggests that exosomes are of paramount importance in distant cell-cell communication because they can enter the circulation when secreted and pass through additional biological barriers. As a result, interest has exploded surrounding the functional parameters of exosomes and their potential applications as delivery vehicles for small molecule therapies. In this review, we discuss the potential of exosomes to be utilized as "natural nanoparticles" to deliver drugs and genes, and their advantages and disadvantages are compared to other delivery mechanisms.

[1]  J. Le Pecq,et al.  A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.

[2]  Chad A. Mirkin,et al.  Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation , 2006, Science.

[3]  H. Geuze,et al.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.

[4]  Shunsuke Noguchi,et al.  Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Toshihiko Yamashita,et al.  Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma , 2005, Journal of Translational Medicine.

[6]  Ralph Weissleder,et al.  Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters , 2015, Nature Communications.

[7]  R. Zhou,et al.  IFITM3‐containing exosome as a novel mediator for anti‐viral response in dengue virus infection , 2014, Cellular microbiology.

[8]  A. Boer,et al.  Strategies to Improve Drug Delivery Across the Blood-Brain Barrier , 2007, Clinical pharmacokinetics.

[9]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[10]  T. D. de Gruijl,et al.  Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.

[11]  M. Czyz,et al.  MiRNA in melanoma-derived exosomes. , 2014, Cancer letters.

[12]  Sung Wan Kim,et al.  Efficient siRNA Delivery with Non-viral Polymeric Vehicles , 2009, Pharmaceutical Research.

[13]  R. Zhuo,et al.  Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy. , 2015, Langmuir : the ACS journal of surfaces and colloids.

[14]  Sungho Jin,et al.  Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.

[15]  Robert Langer,et al.  Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates , 2008, Proceedings of the National Academy of Sciences.

[16]  M. V. Filatov,et al.  Exosomes are natural carriers of exogenous siRNA to human cells in vitro , 2013, Cell Communication and Signaling.

[17]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[18]  I. Sargent,et al.  Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. , 2012, Placenta.

[19]  M. Chopp,et al.  Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. , 2015, Journal of neurosurgery.

[20]  M. Chopp,et al.  Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Per Sunnerhagen,et al.  Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes , 2012, Nucleic acids research.

[22]  Cobi J. Heijnen,et al.  Exosomes: A New Weapon to Treat the Central Nervous System , 2013, Molecular Neurobiology.

[23]  W. Ding,et al.  Intercellular Communication by Exosome-Derived microRNAs in Cancer , 2013, International journal of molecular sciences.

[24]  J. Garssen,et al.  Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures , 2014, Journal of extracellular vesicles.

[25]  W. Hammerschmidt,et al.  EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL , 2011, PloS one.

[26]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[27]  Dongmei Sun,et al.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  H. Yin,et al.  Tumor‐derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro , 2016, Hepatology.

[29]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[30]  R. Johnstone,et al.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.

[31]  P. Altevogt,et al.  Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment , 2015, Oncoimmunology.

[32]  R. Simpson,et al.  Proteomic profiling of exosomes: Current perspectives , 2008, Proteomics.

[33]  M. Wood,et al.  Exosomes for targeted siRNA delivery across biological barriers. , 2013, Advanced drug delivery reviews.

[34]  Jaesung Park,et al.  Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.

[35]  Daehee Hwang,et al.  Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells , 2009, BMC Genomics.

[36]  Richard J Simpson,et al.  Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. , 2012, Methods.

[37]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[38]  Y. Tabata,et al.  Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[39]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[40]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[41]  D. Maria,et al.  Evaluation in melanoma‐bearing mice of an etoposide derivative associated to a cholesterol‐rich nanoemulsion , 2006, The Journal of pharmacy and pharmacology.

[42]  M. Record,et al.  Exosomes as intercellular signalosomes and pharmacological effectors. , 2011, Biochemical pharmacology.

[43]  J. Lötvall,et al.  Isolation and Characterization of RNA-Containing Exosomes , 2012, Journal of visualized experiments : JoVE.

[44]  Q. Ping,et al.  Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. , 2009, International journal of pharmaceutics.

[45]  Y. Tabata,et al.  Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Myung Soo Kim,et al.  Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[47]  Aled Clayton,et al.  Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59 , 2003, European journal of immunology.

[48]  J. Baulch,et al.  Cranial grafting of stem cell-derived microvesicles improves cognition and reduces neuropathology in the irradiated brain , 2016, Proceedings of the National Academy of Sciences.

[49]  A. Möller,et al.  Optimized exosome isolation protocol for cell culture supernatant and human plasma , 2015, Journal of extracellular vesicles.

[50]  Michael Liem,et al.  Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma , 2013, Proteomics.

[51]  J. Lötvall,et al.  EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles , 2013, Journal of extracellular vesicles.

[52]  Jun Qin,et al.  Functions and application of exosomes. , 2014, Acta poloniae pharmaceutica.

[53]  Ashutosh Chilkoti,et al.  Co‐opting biology to deliver drugs , 2014, Biotechnology and bioengineering.

[54]  S. Pluchino,et al.  Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases , 2015, Biogerontology.

[55]  Shinobu Ueda,et al.  Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[56]  R. Schiffelers,et al.  Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.

[57]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[58]  J. Lötvall,et al.  The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles , 2014, Journal of extracellular vesicles.

[59]  R. Schiffelers,et al.  Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[60]  Aled Clayton,et al.  Adhesion and signaling by B cell‐derived exosomes: the role of integrins , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  Dongmei Sun,et al.  Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[62]  B. Pan,et al.  Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor , 1983, Cell.

[63]  C. Mirkin,et al.  Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agents. , 2014, Small.

[64]  Clotilde Théry,et al.  Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses , 2011, Traffic.

[65]  György Nagy,et al.  Cellular and Molecular Life Sciences REVIEW Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles , 2022 .

[66]  G. Raposo,et al.  Exosomes: a common pathway for a specialized function. , 2006, Journal of biochemistry.

[67]  Mauro Ferrari,et al.  Nanogeometry: beyond drug delivery. , 2008, Nature nanotechnology.

[68]  E. Bieberich,et al.  Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease , 2014, Neurobiology of Aging.

[69]  Susanne Gabrielsson,et al.  Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro , 2011, The Journal of Immunology.

[70]  Olivier Lantz,et al.  Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial , 2005, Journal of Translational Medicine.

[71]  Richa Gupta,et al.  Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[72]  D. Momekova,et al.  Star-shaped nano-conjugates of cisplatin with high drug payload. , 2011, International journal of pharmaceutics.

[73]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[74]  Aiman S Saab,et al.  Neurotransmitter-Triggered Transfer of Exosomes Mediates Oligodendrocyte–Neuron Communication , 2013, PLoS biology.

[75]  G. Raposo,et al.  As we wait: coping with an imperfect nomenclature for extracellular vesicles , 2013, Journal of extracellular vesicles.

[76]  S. Tyagi,et al.  Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia. , 2014, Life sciences.

[77]  M. Chopp,et al.  Exosomes in stroke pathogenesis and therapy. , 2016, The Journal of clinical investigation.

[78]  M. Setou,et al.  Functionalized nano-magnetic particles for an in vivo delivery system. , 2007, Journal of nanoscience and nanotechnology.

[79]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[80]  Silvia Maria Doglia,et al.  Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[81]  Y. Tabata,et al.  Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection. , 2012, Molecular pharmaceutics.

[82]  R. Setterquist,et al.  Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. , 2012, Biochimica et biophysica acta.

[83]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[84]  J. Gehl,et al.  Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.

[85]  Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics , 2014, Molecular Neurobiology.

[86]  Jacco van Rheenen,et al.  In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior , 2015, Cell.

[87]  M. Ashraf,et al.  Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. , 2013, Biochemical and biophysical research communications.

[88]  M. Wood,et al.  Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[89]  Jun Lu,et al.  Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. , 2013, The Journal of allergy and clinical immunology.

[90]  Raghu Kalluri,et al.  Exosomes in tumor microenvironment influence cancer progression and metastasis , 2013, Journal of Molecular Medicine.

[91]  Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases , 2013, Metabolic Brain Disease.

[92]  Qiang Zhou,et al.  Cellular Internalization of Exosomes Occurs Through Phagocytosis , 2010, Traffic.

[93]  Y. Tabata,et al.  Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[94]  Y. Tabata,et al.  Reversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/DNA nanoparticles. , 2014, Journal of biomedical nanotechnology.

[95]  Michael Schmidt,et al.  Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. , 2010, ACS nano.

[96]  Andreas Tauch,et al.  CoryneRegNet 6.0—Updated database content, new analysis methods and novel features focusing on community demands , 2011, Nucleic Acids Res..

[97]  Samuel A Wickline,et al.  Maximizing exosome colloidal stability following electroporation. , 2014, Analytical biochemistry.

[98]  Y. Tabata,et al.  Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering. , 2014, Acta biomaterialia.

[99]  M. Campiglio,et al.  Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy , 2012, Journal of cellular physiology.